Further, while the hepatic abundance of C16:0 ceramide is reduced in CerS6 as well as CerS5 knockout mice, only CerS6 deficient mice are protected from HFD-fed obesity, hepatic steatosis, glucose intolerance, and insulin resistance [73]. This evidence concerns the gene CERS6 and obesity disorder.